Understanding Financial Toxicity in Patients with Head and Neck Cancer: A Systematic Review.

ABSTRACT:

Background

Cancer treatment often results in financial burdens for patients including healthcare costs as well as treatment-induced disability leading to "financial toxicity" (FT) and decreased quality of life. The purpose of this review is to describe FT related to head and neck cancer (HNC) treatment, including quantifications of direct and indirect costs and descriptions of measurement tools.

Methods

PubMed, Embase, Cochrane Library, and Web of Science databases were searched to identify articles published before April 2022. Full-text published studies were included if they assessed direct or indirect costs of HNC treatment; studies were excluded if they did not focus on HNC or financial burden. The risk of bias was assessed, and the results of the studies were synthesize

SUBMITTER: Rosi-Schumacher M 

PROVIDER: S-EPMC9880590 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature